The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2018 | Multiple myeloma musings: highlights from 2018 data
Joshua Richter, MD, of Mount Sinai Medical Center, New York, NY, gives us his take on the key highlights in multiple myeloma (MM) from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA. Dr Richter discusses the up-and-coming new tools being investigated in clinical trials, and also reveals the use of old tools in novel ways, notably in the MAIA study (NCT02252172).
